// App-Quantinova.ai

e19345 : Real-world outcomes among patients with epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in first-line setting.

Researchers

Presenter

  • Daniel Simmons

Principal Investigators

  • Maral Der Sarkissian

  • Rahul Shenolikar

  • Min-Jung Wang

  • Angela Lax

  • Aruna Muthukumar

  • Franois Lalibert

  • Mei Sheng Duh

Medical Centers

  • AstraZeneca, Gaithersburg, MD

  • Analysis Group, Inc., Los Angeles, CA

  • Analysis Group, Inc., Boston, MA

  • Analysis Group, Inc., Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • Analysis Group, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

  • Techniclone TNT

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved